Financials • Investment Managers
$29.02 ▲ +0.34
(+1.19%)
MKT CAP: $12.81B • VOL: 3.84M
52W L $22 52W H $34
IVZ // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $6.38B | $6.07B | $5.72B |
| YoY Revenue Growth % | +5.1% | +6.1% | — |
| Gross Profit | $2.81B | $2.67B | $2.52B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$695.7M | $832.1M | -$434.8M |
| Operating Margin % | -10.9% | 13.7% | -7.6% |
| Net Income (GAAP) | $0 | $538.0M | -$333.7M |
| EBITDA (Normalized) | -$628.3M | $887.4M | -$229.0M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.53B | $1.19B | $1.30B |
| Capital Expenditures (CapEx) | $84.3M | $69.1M | $257.2M |
| Free Cash Flow (FCF) | $1.44B | $1.12B | $1.04B |
| FCF Margin % | 22.6% | 18.5% | 18.3% |
| Return on Invested Capital (ROIC %) | -3.1% | 3.5% | -8.1% |
| Cash & Short-Term Equivalents | $1.04B | $986.5M | $775.1M |
| Total Debt (Short + Long Term) | $6.34B | $5.10B | $1.65B |
| Total Stockholders' Equity | $12.23B | $14.56B | $3.38B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR IVZ.